EyePoint (EYPT) Non-Current Deferred Tax Liability (2011)

EyePoint (EYPT) reported Non-Current Deferred Tax Liability of $13000.0 for Q2 2011.

EyePoint (EYPT) Non-Current Deferred Tax Liability (2011) Analysis & Trends

EyePoint (EYPT) has 1 years of Non-Current Deferred Tax Liability data on file, last reported at $13000.0 in Q2 2011.

For the quarter ending Q2 2011, Non-Current Deferred Tax Liability changed N/A year-over-year to $13000.0; the trailing twelve-month figure through Jun 2011 stood at $13000.0 (changed N/A YoY), and the FY2011 full-year result was $13000.0, changed N/A from the prior year.
Non-Current Deferred Tax Liability held at $13000.0 in Q2 2011.
In the past five years, Non-Current Deferred Tax Liability ranged from a high of $13000.0 in Q2 2011 to a low of $13000.0 in Q2 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	EyePoint	358.61 Mn	136.07 Mn	168,000.00

Download Data

Date	Value
Jun 30, 2011	13,000.00
Jun 30, 2011	13,000.00